EndGenitor Technologies, Inc

Regenerating Our Lives

Home

 EndGenitor is committed to developing novel methods to collect, expand, and cryopreserve adult stem cells to treat patients with a variety of life threatening illnesses.  The company is also engaging in research of stem cell differentiation biology, in order to further unlock the exciting potential of this therapeutic approach.

 

 

“Developing novel adult stem cell  products for regenerative medicine”

EndGenitor is using cord blood derived cells  to develop proprietary novel stem cell therapeutic products for the treatment of debilitating chronic degenerative diseases. 

Home

About Us

Technology

Management

Related Publications

Contact Us